Stratec Biomedical AG Stock Xetra
Equities
DE0007289001
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Jul. 01 | STRATEC BIOMEDICAL SYSTEMS AG : Gets a Neutral rating from Deutsche Bank | ZD |
Jun. 11 | STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research reiterates its Neutral rating | ZD |
Sales 2024 * | 267M 292M | Sales 2025 * | 289M 316M | Capitalization | 517M 565M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.49M | Net income 2025 * | 23M 25.14M | EV / Sales 2024 * | 2.37 x |
Net Debt 2024 * | 116M 127M | Net Debt 2025 * | 85.83M 93.81M | EV / Sales 2025 * | 2.09 x |
P/E ratio 2024 * |
31.7
x | P/E ratio 2025 * |
22.3
x | Employees | - |
Yield 2024 * |
2.05% | Yield 2025 * |
2.13% | Free-Float | 59.43% |
Latest transcript on Stratec Biomedical AG
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 57 | 98-02-28 |
Robert Siegle
DFI | Director of Finance/CFO | 57 | 98-04-30 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 58 | 19-05-28 |
Georg Heni
CHM | Chairman | 66 | 22-05-19 |
Rolf Vornhagen
BRD | Director/Board Member | 71 | 20-07-20 |
1st Jan change | Capi. | |
---|---|---|
+4.57% | 212B | |
+8.61% | 186B | |
+26.34% | 151B | |
+33.90% | 114B | |
+2.97% | 65.57B | |
+14.50% | 52.61B | |
-3.30% | 46.8B | |
-3.98% | 38.95B | |
+6.66% | 37.64B |